IHI - ETF AI Analysis

Top Page

iShares U.S. Medical Devices ETF (IHI)

Rating:74Outperform

Price Target:―

IHI, the iShares U.S. Medical Devices ETF, earns a solid overall rating driven by strong, growth-focused leaders like Abbott Laboratories and Intuitive Surgical, which benefit from robust financial performance and positive outlooks in the medical devices space. Medtronic and Edwards Lifesciences also support the fund’s quality with innovation and healthy sales trends, though their premium valuations add some risk. The main risk factor is the fund’s concentration in a single industry—U.S. medical devices—where several holdings face high valuations and occasional bearish or cautious technical signals.

Positive Factors

Strong Top Holdings

Several key holdings, such as Abbott Laboratories and Boston Scientific, have delivered strong year-to-date performance, supporting the fund’s overall returns.

Focused Sector Exposure

The ETF’s concentration in the health care sector provides targeted exposure to a growing industry with long-term demand drivers.

Reasonable Expense Ratio

The fund’s expense ratio is relatively low for a specialized sector ETF, allowing investors to keep more of their returns.

Negative Factors

High Concentration in Top Holdings

The top three holdings make up a significant portion of the portfolio, increasing the risk tied to their individual performance.

Underperforming Holdings

Some holdings, such as Intuitive Surgical and Becton Dickinson, have lagged this year, which could drag on the ETF’s overall performance.

Limited Geographic Diversification

With nearly all assets invested in U.S. companies, the fund lacks exposure to international markets, which could limit diversification benefits.

IHI vs. SPDR S&P 500 ETF (SPY)

AUM4.12B

RegionNorth America

Expense Ratio0.38%

Beta0.69

IssueriShares

Inception DateMay 01, 2006

Dividend Yield0.33%

Asset ClassEquity

Index TrackedDJ US Select / Medical Equipment

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume860,872

30 Day Avg. Volume1,240,904

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

73.52

Price Target Upside― Downside

Rating ConsensusStrong Buy

Number of Analyst Covering47

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IHI Summary

The iShares U.S. Medical Devices ETF (IHI) focuses on companies in the U.S. medical devices industry, which includes innovative healthcare technologies like surgical instruments and diagnostic tools. It tracks an index of medical equipment companies, offering exposure to well-known names like Abbott Laboratories and Intuitive Surgical. This ETF could be appealing to investors looking for growth opportunities in the healthcare sector, as the demand for advanced medical solutions continues to rise. However, new investors should be aware that the fund’s performance is closely tied to the healthcare industry, which can be affected by regulatory changes and market conditions.

How much will it cost me?The iShares U.S. Medical Devices ETF (IHI) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which typically involves more specialized management compared to broad-market passive funds.

What would affect this ETF?The iShares U.S. Medical Devices ETF (IHI) could benefit from growing demand for advanced healthcare solutions and technological innovations in medical devices, driven by an aging population and increased focus on personalized medicine. However, potential risks include regulatory changes, pricing pressures, and economic downturns that may impact healthcare spending, as well as competition among top holdings like Abbott Laboratories and Intuitive Surgical. The ETF’s focus on U.S.-based companies may also limit exposure to growth opportunities in international markets.

IHI Top 10 Holdings

The iShares U.S. Medical Devices ETF (IHI) is heavily concentrated in the health care equipment sector, with top holdings like Abbott Laboratories and Intuitive Surgical leading the charge. Intuitive Surgical is rising steadily, buoyed by strong operational metrics and strategic initiatives, while Abbott is losing steam amid bearish momentum. Boston Scientific and Edwards Lifesciences provide mixed signals, with solid growth offset by valuation concerns. Meanwhile, Stryker and Resmed are lagging, weighed down by bearish trends and premium valuations. Overall, the fund’s U.S.-focused portfolio leans heavily on innovation in medical technology, but some names are struggling to keep pace.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ABT	Abbott Laboratories	17.27%	$729.96M	$219.88B	12.68%	73 Outperform
ISRG	Intuitive Surgical	16.33%	$690.43M	$200.78B	11.46%	78 Outperform
BSX	Boston Scientific	11.27%	$476.26M	$141.54B	6.30%	79 Outperform
SYK	Stryker	4.50%	$190.27M	$133.39B	3.16%	70 Outperform
BDX	Becton Dickinson	4.50%	$190.15M	$56.69B	-11.54%	67 Neutral
GEHC	GE Healthcare Technologies Inc	4.46%	$188.63M	$38.74B	4.03%	78 Outperform
EW	Edwards Lifesciences	4.44%	$187.92M	$48.84B	16.58%	79 Outperform
IDXX	Idexx Laboratories	4.38%	$185.00M	$54.48B	65.43%	78 Outperform
MDT	Medtronic	4.33%	$182.85M	$124.82B	25.59%	80 Outperform
RMD	Resmed	4.17%	$176.13M	$35.81B	5.41%	76 Outperform

IHI Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

62.32

Positive

100DMA

61.56

Positive

200DMA

60.89

Positive

Market Momentum

MACD

0.18

Negative

RSI

64.89

Neutral

STOCH

62.61

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IHI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 62.52, equal to the 50-day MA of 62.32, and equal to the 200-day MA of 60.89, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 64.89 is Neutral, neither overbought nor oversold. The STOCH value of 62.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IHI.

IHI Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IHI	―	―	$4.12B	0.38%	―
IBB	―	―	$8.37B	0.44%	―
XBI	―	―	$7.86B	0.35%	―
IYH	―	―	$3.58B	0.38%	―
FHLC	―	―	$2.85B	0.08%	―
FBT	―	―	$1.32B	0.54%	―

Performance Comparison

IHI

iShares U.S. Medical Devices ETF

64.40

4.21

6.99%

IBB

iShares Biotechnology ETF

―

XBI

SPDR S&P BIOTECH ETF

―

IYH

iShares U.S. Healthcare ETF

―

FHLC

Fidelity MSCI Health Care Index ETF

―

FBT

First Trust NYSE Arca Biotechnology Index Fund

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents